Rapid Micro Biosystems, Inc. Class A (RPID) Dividend History

Rapid Micro Biosystems, Inc. Class A (RPID) specializes in real-time microbiology solutions for the pharmaceutical, biotech, and food industries. The company develops automated systems and reagents to optimize microbial testing processes, improve accuracy, and reduce turnaround times for quality control laboratories. Their technology aims to enhance laboratory efficiency and ensure compliance with industry regulations.

25 Hartwell Avenue, Lexington, MA, 02421
Phone: 978-349-3200
Website:

Dividend History

Rapid Micro Biosystems, Inc. Class A currently does not pay dividends

Company News

  • Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

    Rapid Micro Biosystems, an innovative life sciences technology company, has welcomed Dr. Dafni Bika to its Board of Directors. Dr. Bika brings over 25 years of experience in pharmaceutical development and manufacturing, which will contribute to the company's growth as it continues to establish its Growth Direct platform as the industry standard for automating pharmaceutical QC testing.

    GlobeNewswire Inc.
    Featured Companies: BMY MRK
  • Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58%

    The pharmaceutical sterility testing market is growing rapidly due to increasing demand for safe and effective pharmaceutical products, advancements in testing technologies, and the rising focus on biopharmaceuticals. The market is expected to reach $3.79 billion by 2032, driven by stringent regulations, the need for sterility testing in new therapies, and the shift towards in-house testing.

    GlobeNewswire Inc.
    Featured Companies: CRL LH SHC STE TMO
  • Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results

    Rapid Micro Biosystems reported record third quarter 2024 revenue of $7.6 million, a 24% increase compared to the prior year. The company placed seven Growth Direct® systems and achieved positive gross margins of 8%, a significant improvement. The company reaffirmed its full-year 2024 revenue guidance of at least $27 million.

    GlobeNewswire Inc.
  • Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results

    Rapid Micro Biosystems reported strong Q2 2024 results, with 32% revenue growth, improved gross margins, and announced an operational efficiency program to achieve positive cash flow. The company reaffirmed its full-year 2024 revenue guidance of at least $27 million.

    GlobeNewswire Inc.
  • Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates

    Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -6.90% and 0.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: CLPT
Dividend data last updated 06/07/2025 01:42:44 UTC